BlackRock Fund Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $82M | Buy |
2,118,355
+108,722
| +5% | +$4.21M | 0.02% | 1348 |
|
|
2016
Q3 | $102M | Buy |
2,009,633
+64,921
| +3% | +$3.29M | 0.02% | 1046 |
|
|
2016
Q2 | $88.4M | Sell |
1,944,712
-1,278,837
| -40% | -$58.1M | 0.02% | 1070 |
|
|
2016
Q1 | $127M | Buy |
3,223,549
+53,137
| +2% | +$2.1M | 0.03% | 758 |
|
|
2015
Q4 | $179M | Sell |
3,170,412
-172,276
| -5% | -$9.75M | 0.04% | 557 |
|
|
2015
Q3 | $133M | Buy |
3,342,688
+167,405
| +5% | +$6.66M | 0.03% | 697 |
|
|
2015
Q2 | $152M | Sell |
3,175,283
-75,059
| -2% | -$3.58M | 0.04% | 656 |
|
|
2015
Q1 | $129M | Buy |
3,250,342
+401,074
| +14% | +$15.9M | 0.03% | 778 |
|
|
2014
Q4 | $63.7M | Buy |
2,849,268
+291,889
| +11% | +$6.52M | 0.02% | 1294 |
|
|
2014
Q3 | $40.1M | Sell |
2,557,379
-19,944
| -0.8% | -$313K | 0.01% | 1499 |
|
|
2014
Q2 | $38.2M | Sell |
2,577,323
-231,213
| -8% | -$3.43M | 0.01% | 1579 |
|
|
2014
Q1 | $45.2M | Buy |
2,808,536
+394,024
| +16% | +$6.34M | 0.01% | 1483 |
|
|
2013
Q4 | $22.6M | Sell |
2,414,512
-37,089
| -2% | -$346K | 0.01% | 1926 |
|
|
2013
Q3 | $27.8M | Buy |
2,451,601
+325,163
| +15% | +$3.68M | 0.01% | 1750 |
|
|
2013
Q2 | $28.5M | Buy |
+2,126,438
| New | +$28.5M | 0.01% | 1599 |
|